These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9858455)

  • 1. Anti-annexin V antibodies and osteonecrosis in systemic lupus erythematosus.
    Sugiura K; Muro Y
    J Rheumatol; 1998 Dec; 25(12):2477-8. PubMed ID: 9858455
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for osteonecrosis in systemic lupus erythematosus.
    Mont MA; Glueck CJ; Pacheco IH; Wang P; Hungerford DS; Petri M
    J Rheumatol; 1997 Apr; 24(4):654-62. PubMed ID: 9101497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-annexin V antibodies: are they prothrombotic?
    Esposito G; Tamby MC; Chanseaud Y; Servettaz A; Guillevin L; Mouthon L
    Autoimmun Rev; 2005 Jan; 4(1):55-60. PubMed ID: 15652780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to beta2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions.
    Zammiti W; Mtiraoui N; Hidar S; Fekih M; Almawi WY; Mahjoub T
    Arch Gynecol Obstet; 2006 Aug; 274(5):261-5. PubMed ID: 16826414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Satoh A; Suzuki K; Takayama E; Kojima K; Hidaka T; Kawakami M; Matsumoto I; Ohsuzu F
    J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein(a) in systemic lupus erythematosus].
    Popkova TV; Pokrovskiĭ SN; Alekberova ZS; Reshetniak TM; Fomicheva OA; Aleksandrova EN; Kliukvina NG; Nasonov EL
    Klin Med (Mosk); 1998; 76(1):21-4. PubMed ID: 9532909
    [No Abstract]   [Full Text] [Related]  

  • 7. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V.
    Zammiti W; Mtiraoui N; Kallel C; Mercier E; Almawi WY; Mahjoub T
    Reproduction; 2006 Apr; 131(4):817-22. PubMed ID: 16595732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-annexin V antibodies and digital ischemia in patients with scleroderma.
    Sugiura K; Muro Y
    J Rheumatol; 1999 Oct; 26(10):2168-72. PubMed ID: 10529134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
    Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Ikeda Y
    Am J Hematol; 1997 Mar; 54(3):209-13. PubMed ID: 9067499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple osteonecrotic lesions in systemic lupus erythematosus.
    Fishel B; Caspi D; Eventov I; Avrahami E; Yaron M
    J Rheumatol; 1987 Jun; 14(3):601-4. PubMed ID: 3625643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Avascular bone necrosis in systemic lupus erythematosus].
    Arturi AS; Babini JC; García Morteo O; Arana R; Maldonado Cocco J; Marcos JC
    Medicina (B Aires); 1980; 40(5):497-500. PubMed ID: 7207182
    [No Abstract]   [Full Text] [Related]  

  • 14. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus.
    Rothschild BM
    J Rheumatol; 2001 Feb; 28(2):455. PubMed ID: 11246696
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-annexin V antibodies in plasma and serum samples from patients with lupus anticoagulant.
    Kuragaki C; Kidoguchi K; Nakamura N; Wada Y
    Am J Hematol; 1995 Sep; 50(1):68. PubMed ID: 7668234
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies.
    Gómez-Zumaquero JM; Tinahones FJ; De Ramón E; Camps M; Garrido L; Soriguer FJ
    Rheumatology (Oxford); 2004 Apr; 43(4):510-3. PubMed ID: 14872100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y; Jia RL; Han L; Li ZG
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
    Nojima J
    Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z
    Neurol Sci; 2003 Nov; 24(4):273-4. PubMed ID: 14658047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.